Peter Watler

Dr. Peter Watler has over three decades of vaccine and biopharmaceutical development and manufacturing experience including a deep knowledge of clinical and commercial manufacturing and partnering with contract manufacturing organizations. He has authored several IND and BLA submissions with participation in FDA inspections and cGMP audits. During his twelve years at Amgen, Dr. Watler led teams responsible for the technology transfer and commercial manufacturing support of Neupogen®, Stemgen®, Kepivance® and Infergen®. He most recently served as Chief Technical Officer of Coherus BioSciences where he established partnerships with leading contract manufacturers and was responsible for the clinical supply chain management and establishing the commercial manufacture of Udenyca®. Dr. Watler also served as Chief Technology Officer at Hyde Engineering where he oversaw the process design of biopharmaceutical manufacturing facilities including a modern modular facility recently built and commissioned in China. Prior to that, he was Vice-President of Manufacturing at Vaxgen, and led the team responsible for the design, build and validation of a vaccine production facility. He also provided design input for Celltrion’s first South Korea manufacturing plant. He received his PhD in chemical engineering from Yamaguchi University, Japan and holds bachelor’s and master’s degrees in chemical engineering from the University of Toronto.